MOLECULAR DIVERSITY

Scope & Guideline

Connecting Chemistry, Biology, and Pharmacology for a Better Tomorrow

Introduction

Immerse yourself in the scholarly insights of MOLECULAR DIVERSITY with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1381-1991
PublisherSPRINGER
Support Open AccessNo
CountrySwitzerland
TypeJournal
Convergefrom 1995 to 1998, 2000, from 2003 to 2024
AbbreviationMOL DIVERS / Mol. Divers.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressVAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS

Aims and Scopes

The journal 'Molecular Diversity' is dedicated to the comprehensive exploration of molecular diversity in chemistry, particularly focusing on the synthesis, characterization, and bioactivity of novel compounds. The journal emphasizes interdisciplinary approaches that integrate traditional synthetic methods with advanced computational techniques to address contemporary challenges in medicinal chemistry, drug discovery, and molecular biology.
  1. Synthetic Chemistry:
    The journal publishes extensive research on novel synthetic methodologies, including multi-component reactions, green chemistry approaches, and environmentally benign synthesis techniques. This includes the development of new reactions and catalysts aimed at improving the efficiency and sustainability of chemical processes.
  2. Medicinal Chemistry:
    Research articles often focus on the design, synthesis, and evaluation of new pharmaceutical compounds, particularly those targeting diseases such as cancer, tuberculosis, and viral infections. This includes structure-activity relationship (SAR) studies and the exploration of molecular mechanisms of action.
  3. Computational Chemistry and Molecular Modeling:
    The integration of computational methods, including molecular docking, molecular dynamics simulations, and quantitative structure-activity relationship (QSAR) modeling, is a prominent feature. This approach aids in understanding molecular interactions and predicting the activity of new compounds.
  4. Natural Products and Pharmacognosy:
    The journal highlights studies that investigate the bioactive potential of natural products and their derivatives, focusing on their roles as lead compounds in drug discovery. Research often involves isolation, characterization, and evaluation of pharmacological activities.
  5. Targeted Drug Design and Repurposing:
    A significant emphasis is placed on the design and identification of inhibitors targeting specific proteins involved in disease pathways, including drug repurposing strategies that utilize existing compounds for new therapeutic applications.
Recent publications in 'Molecular Diversity' indicate emerging trends and themes that are gaining significance. These reflect the current priorities in molecular research and the ongoing challenges faced in various fields, particularly in drug discovery and development.
  1. Artificial Intelligence and Machine Learning in Drug Discovery:
    There is an increasing incorporation of AI and machine learning techniques to facilitate drug discovery processes. This includes predictive modeling for bioactivity, virtual screening, and optimizing synthetic routes, which represents a significant trend in modern medicinal chemistry.
  2. Focus on Viral Infections:
    Research targeting viral infections, particularly those related to COVID-19, has surged. This includes studies on drug repurposing, the design of antiviral agents, and understanding viral mechanisms, reflecting an urgent response to global health challenges.
  3. Network Pharmacology:
    The application of network pharmacology is gaining traction, emphasizing the understanding of complex biological interactions and pathways. This approach aids in identifying potential therapeutic targets and understanding the multi-target effects of compounds.
  4. Sustainable and Green Chemistry Practices:
    There is a marked increase in studies emphasizing sustainable synthesis and environmentally friendly methodologies. Researchers are focusing on reducing the environmental impact of chemical processes through innovative synthetic strategies.
  5. Natural Product Derivatives:
    The exploration of natural product derivatives continues to rise, particularly in the context of drug discovery. This includes the synthesis and evaluation of compounds derived from plants and marine sources, which are being investigated for their therapeutic potential.

Declining or Waning

While 'Molecular Diversity' has a robust focus on several key areas, some themes appear to be declining in prominence based on recent publications. This reflects the evolving landscape of research interests and the shifting priorities within the scientific community.
  1. Traditional Synthetic Methods:
    There is a noticeable decrease in studies focusing solely on conventional synthetic methods without the integration of advanced techniques or green chemistry principles. The trend is moving towards more innovative and sustainable approaches.
  2. Basic Pharmacological Studies:
    The journal has seen fewer articles that solely present basic pharmacological studies without a strong emphasis on molecular mechanisms or computational analysis. Research is increasingly expected to provide deeper insights into the mechanistic aspects of drug action.
  3. Broad-Spectrum Antibacterial Agents:
    Research on broad-spectrum antibacterial agents has become less frequent as the focus shifts towards more targeted therapies that address specific bacterial mechanisms of resistance, particularly in the context of rising antibiotic resistance.
  4. Non-Computational Approaches:
    There appears to be a decline in the publication of studies that do not incorporate computational methods. The integration of computational analyses is becoming a standard expectation in research, leading to fewer standalone experimental studies.

Similar Journals

Frontiers in Chemistry

Pioneering Discoveries in the World of Chemistry.
Publisher: FRONTIERS MEDIA SAISSN: 2296-2646Frequency: 1 issue/year

Frontiers in Chemistry is an esteemed and innovative Open Access journal published by FRONTIERS MEDIA SA, based in Lausanne, Switzerland. Since its inception in 2013, the journal has established itself as a leading platform for the dissemination of high-quality research across a broad spectrum of chemistry disciplines, achieving a notable Q1 classification in the miscellaneous chemistry category as of 2023. With an impressive Scopus rank, placing it at 72nd out of 408 in General Chemistry and falling within the 82nd percentile, Frontiers in Chemistry is committed to publishing significant findings that contribute to the advancement of the field. The journal's Open Access model ensures that research is freely accessible to all, fostering a greater exchange of knowledge and collaboration among researchers, professionals, and students globally. It covers a range of topics, from organic and inorganic chemistry to materials science and biochemistry, making it an essential resource for anyone seeking to stay at the forefront of chemical research.

REVUE ROUMAINE DE CHIMIE

Pioneering Research: Where Romanian Chemistry Meets the World
Publisher: EDITURA ACAD ROMANEISSN: 0035-3930Frequency: 12 issues/year

REVUE ROUMAINE DE CHIMIE is a distinguished academic journal in the field of chemistry, published by EDITURA ACAD ROMANE in Romania. With an ISSN of 0035-3930, this journal has been a valuable platform for disseminating original research and insights in the diverse realm of chemistry since its inception. The journal currently operates under a competitive tier, categorized in Q4 for miscellaneous chemistry fields, as reflected in its Scopus ranking of #348 out of 408, placing it within the 14th percentile. Aiming to foster scientific discourse and innovation, the REVUE ROUMAINE DE CHIMIE provides a repository of knowledge that is crucial for researchers, professionals, and students eager to advance their understanding and contribute to the global chemistry community. By bridging local and international research initiatives, this journal plays an essential role in enhancing the visibility of Romanian scientific contributions on the world stage.

BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN

Showcasing Excellence: A Nexus for Chemical Scholarship
Publisher: CHEMICAL SOC JAPANISSN: 0009-2673Frequency: 12 issues/year

BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN, published by the esteemed Chemical Society of Japan, serves as a pivotal platform for the dissemination of cutting-edge research in the multifaceted field of chemistry. With an ISSN of 0009-2673 and an E-ISSN of 1348-0634, this journal has been integral in fostering the growth of chemical sciences globally since its inception in 1965. The journal holds an impressive Q2 ranking in the Chemistry (miscellaneous) category, indicating its relevance and influence within the academic community, as reflected by its Scopus rank of #104/408, placing it in the 74th percentile. Although it is not an open-access journal, its rich content, which spans a wide range of topics in general chemistry, remains highly valued by researchers, professionals, and students alike, affirming its crucial role in advancing both theoretical knowledge and practical applications in chemistry. As it converges towards 2024, the bulletin continues to uphold its commitment to excellence in scientific communication and research dissemination in Japan and beyond.

Heterocyclic Letters

Advancing Knowledge in Synthetic Organic Chemistry
Publisher: RAMAN PUBLISSN: 2231-3087Frequency: 4 issues/year

Heterocyclic Letters is an esteemed journal in the field of synthetic organic chemistry, published by RAMAN PUBL. With ISSN 2231-3087 and E-ISSN 2230-9632, this journal aims to disseminate original research and innovative findings related to heterocyclic compounds, which play a crucial role in medicinal chemistry, material science, and agricultural chemistry. Heterocyclic Letters provides a platform for researchers, professionals, and students to share their insights and advancements, thus fostering academic collaboration and knowledge transfer. The journal is dedicated to maintaining high-quality standards in research publication, making it an essential resource for anyone focused on the latest developments in heterocyclic chemistry. Although it does not currently offer Open Access options, the journal’s rigorous peer-review process ensures that only the most credible and impactful studies are published, contributing significantly to the advancement of the field.

CHEMISTRY LETTERS

Innovative insights for the chemistry community.
Publisher: CHEMICAL SOC JAPANISSN: 0366-7022Frequency: 12 issues/year

Chemistry Letters, published by the Chemical Society of Japan, is a distinguished academic journal that focuses on pivotal developments in the field of chemistry. Since its inception in 1973, the journal has been a vital platform for the dissemination of novel research findings across various sub-disciplines, encompassing both theoretical advancements and practical applications. As a testament to its significance in the community, Chemistry Letters has achieved a Category Quartile of Q2 in the 2023 ranking for miscellaneous Chemistry journals, reflecting its respected position among peers. Although it does not offer Open Access, the journal remains accessible through institutional subscriptions, thus ensuring a wide reach for its valuable content. With an active scope ranging from general chemistry topics to specialized studies, it is ideal for researchers, professionals, and students alike who seek to contribute to and expand their knowledge within this dynamic field. The journal continuously aims to promote excellence in chemical research, facilitating dialogue and collaboration among chemists worldwide.

ACS Bio & Med Chem Au

Elevating biomedical research through open access and collaboration.
Publisher: AMER CHEMICAL SOCISSN: Frequency: 6 issues/year

ACS Bio & Med Chem Au, published by the esteemed American Chemical Society, stands at the forefront of interdisciplinary research within the realms of biochemistry, drug discovery, pharmaceutical sciences, and molecular biology. With an impressive Impact Factor indicative of its rigorous academic standards and significant contributions to the field, this open-access journal is committed to disseminating high-quality research that drives innovation and advancements in biosciences and medicinal chemistry. Since its inception in 2021, the journal has rapidly earned recognition, achieving a commendable Q1 ranking in multiple categories, including Biochemistry, Drug Discovery, and Pharmaceutical Science, while also making strides in Molecular Biology. Researchers, professionals, and students alike can explore pioneering studies that bridge gaps between laboratory research and clinical applications, fostering collaborative efforts towards novel therapeutic strategies. With a focus on enhancing accessibility and engagement within the scientific community, ACS Bio & Med Chem Au is poised to impact the future of biomedical research significantly.

CURRENT MEDICINAL CHEMISTRY

Catalyzing Breakthroughs in Health Sciences.
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 0929-8673Frequency: 42 issues/year

Current Medicinal Chemistry is a leading journal published by Bentham Science Publishers Ltd, known for its rigorous focus on the multifaceted realm of medicinal chemistry. With an ISSN of 0929-8673 and E-ISSN 1875-533X, the journal plays a crucial role in disseminating high-quality research findings that bridge the gap between chemistry and health sciences. Operating from Sharjah, United Arab Emirates, it has been a prominent scholarly resource since its inception in 1994, and is expected to continue until 2024. Current Medicinal Chemistry has earned its place in the academic community with an impressive impact factor and categorization in Q1 and Q2 quartiles across various disciplines, including Organic Chemistry, Biochemistry, Drug Discovery, and Pharmacology, highlighting its substantial contribution to these fields. Notably, it ranks 24th in Organic Chemistry and is within the 88th percentile, underscoring its appeal to researchers, professionals, and students alike who are keen on exploring cutting-edge advancements in drug design and development. Although it is not an open-access journal, it provides vital content that informs and inspires innovation in medicinal chemistry, appealing to a global audience committed to enhancing human health through scientific discovery.

JOURNAL OF MOLECULAR MODELING

Pioneering Research in Molecular Modeling and Beyond
Publisher: SPRINGERISSN: 1610-2940Frequency: 1 issue/year

JOURNAL OF MOLECULAR MODELING, published by Springer, is a pivotal resource for researchers and professionals in the fields of chemistry, computer science, and molecular sciences. The journal's ISSN is 1610-2940, with an E-ISSN of 0948-5023, reflecting its commitment to disseminating cutting-edge research from 1996 to 2024. Although the journal does not operate under an Open Access model, it remains an invaluable platform for the publication of innovative studies related to computational methods, theoretical chemistry, and molecular simulations. With a notable categorization across multiple quartiles—including Q4 in Catalysis and Q3 in Computational Theory and Mathematics—the journal holds a distinct rank in Scopus, highlighting its influence and contribution to the discipline. The importance of this journal lies in its ability to bridge the gap between theoretical understanding and practical applications, making it essential reading for students and scholars seeking to advance their knowledge and research in molecular modeling.

Chemical Biology & Drug Design

Pioneering the intersection of chemistry and medicine for a healthier future.
Publisher: WILEYISSN: 1747-0277Frequency: 12 issues/year

Chemical Biology & Drug Design, an esteemed publication by WILEY, serves as a vital platform for the dissemination of pioneering research in the interdisciplinary fields of biochemistry, drug discovery, molecular medicine, organic chemistry, and pharmacology. With a dedicated commitment to advancing the understanding of chemical interactions and drug development, this journal not only fosters innovation but also bridges the gap between theoretical research and practical applications. It boasts an impressive impact factor and is recognized in the 2023 category quartiles as Q3 in Biochemistry and Molecular Medicine, and Q2 in Drug Discovery, Organic Chemistry, and Pharmacology, indicating its relevance and influence in these crucial areas. The journal’s rankings across various Scopus categories further solidify its position as a reputable resource for researchers, professionals, and students striving to stay at the forefront of medicinal chemistry and drug design. While primarily traditional access-based, the journal's evolving scope from 2006 to 2024 ensures an ongoing contribution to essential scientific dialogue, making it an indispensable read for those committed to advancing health sciences.

RUSSIAN CHEMICAL REVIEWS

Pioneering Reviews for a Dynamic Chemical Landscape
Publisher: ND Zelinsky Inst Organic Chemistry, RAS - ZIOC RASISSN: 0036-021XFrequency: 12 issues/year

RUSSIAN CHEMICAL REVIEWS, published by the esteemed ND Zelinsky Institute of Organic Chemistry, RAS, stands as a prominent platform for disseminating high-quality research in the diverse field of chemistry. With an ISSN of 0036-021X and an E-ISSN of 1468-4837, this journal has earned its place in the Q1 quartile of Chemistry (miscellaneous) for 2023, reflecting its outstanding impact and rigorous peer-review process. The journal encompasses a wide array of topics within chemistry, providing critical reviews that advance understanding and foster collaboration among researchers, professionals, and students globally. With its consistent publication since 1970, RUSSIAN CHEMICAL REVIEWS not only serves as a valuable resource for the latest advancements in the field but also plays a crucial role in shaping future research directions. The journal is based in the Russian Federation, with its office located at 47 Leninsky Pr, Moscow 119991, RUSSIA. As an essential reference for those in the chemical sciences, it provides an ideal avenue for authors looking to publish impactful reviews that contribute to the broader scientific community.